AssetMark’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
AssetMark's IART Position: Q3 2026 in Review
AssetMark opened a new position in Integra LifeSciences (IART) in Q3 2026: 13 shares worth $212. The stake represents ﹤0.01% of the portfolio and ranks #3599 among its holdings. This is a return to the name: AssetMark previously reported a position in IART as recently as Q2 2024.
AssetMark first reported a position in IART in Q3 2016 and has held it in 25 quarters since. The position peaked at $2.71M in Q1 2017. 179 funds tracked by Wall St. Rank hold IART as of Q3 2026.
- AssetMark held 13 shares of Integra LifeSciences worth $212 as of Q3 2026.
- Integra LifeSciences was a new AssetMark position in Q3 2026.
- Integra LifeSciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3599 holding.
- AssetMark first reported a position in Integra LifeSciences in Q3 2016 and has held it in 25 quarters since.
- AssetMark's Integra LifeSciences position peaked at $2.71M in Q1 2017.
- 179 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.